Related Experiment Videos
Antibiotic-loaded acrylic cement: current concepts.
Clinical Orthopaedics and Related Research
|November 1, 1984
Summary
Antibiotic-loaded acrylic cement shows a 77% success rate for infected total hip arthroplasties, with Pseudomonas infections posing a significant risk. This data aids in understanding treatment outcomes for joint replacements.
Area of Science:
- Orthopedic Surgery
- Biomaterials Science
- Infectious Disease
Background:
- Antibiotic-loaded acrylic cement has been a routine material in joint arthroplasty since 1972.
- Over 22,000 joint arthroplasty operations were performed between 1964-1983 using this material.
- Previous follow-up statistics on prophylactic therapy and deep infections have been published.
Purpose of the Study:
- To present the current status and updated follow-up statistics of antibiotic-loaded acrylic cement in joint arthroplasty.
- To compare the results of 869 exchange arthroplasties with previously published data.
- To introduce the use of survival curves for future analysis and comparison of treatment outcomes.
Main Methods:
- Retrospective actuarial analysis of 825 one-stage reimplantations for infected total hip arthroplasties.
- Utilized antibiotic-loaded acrylic cement in all cases.
- Statistical comparison of failure rates for different microorganisms, including Staphylococcus aureus, S. species, and Pseudomonas.
Main Results:
- Staphylococcus aureus was the most frequently identified organism in infected prostheses.
- Failure rates for prostheses infected by S. aureus, S. species, and anaerobic corynebacteria were not statistically different.
- Pseudomonas infection was identified as a significant factor contributing to treatment failure.
Conclusions:
- The study calculated a 77% success (survival) rate five years after operation for infected total hip arthroplasties treated with antibiotic-loaded acrylic cement.
- Survival curves are recommended for ease of comparison and analysis of covariable factors in future studies.
- While effective, Pseudomonas infections present a challenge to the success of this treatment method.